Clinical significance of a NAD(P)H: Quinone oxidoreductase 1 polymorphism in patients with disseminated peritoneal cancer receiving intraperitoneal hyperthermic chemotherapy with mitomycin C

Pharmacogenetics

Volumn 12, Issue 1, 2002, Pages 31-37

  Fleming, Ronald A ^a   Drees, Jeffrey ^a   Loggie, Brian W ^a   Russell, Gregory B ^a   Geisinger, Kim R ^a   Morris, Reba T ^a   Sachs, Debbie ^a   McQuellon, Richard P ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Mitomycin C; NQO1; Polymorphism

Indexed keywords

MITOMYCIN C; OXIDOREDUCTASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE);

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SURVIVAL; DIGESTIVE SYSTEM CANCER; FEMALE; GENE ACTIVITY; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HUMAN; HUMAN TISSUE; MALE; PERITONEUM CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTINEOPLASTIC; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; DNA PRIMERS; FEMALE; GENOTYPE; HUMANS; HYPERTHERMIA, INDUCED; MALE; MIDDLE AGED; MITOMYCIN; NAD(P)H DEHYDROGENASE (QUINONE); PERITONEAL NEOPLASMS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SURVIVAL RATE;

EID: 0036158312     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-200201000-00005     Document Type: Article

References (27)

1. Antitumor antibiotics
2. DT-diaphorase in activation and detoxification of quinones
3. NAD(P)H: Quinone oxidoreductase gene expression in human colon carcinoma cells: Characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity
4. Elevated DT-diaphorase activity and messenger RNA content in human non-small cell lung carcinoma: Relationship to the response of lung tumor xenographs to mitomycin c
5. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin
6. Treatment and prevention of malignant ascites associated with disseminated intraperitoneal malignancies by aggressive combined-modality therapy
7. Loss of heterozygosity at the NAD(P)H: Quinone oxidoreductase locus associated with increased resistance against mitomycin C in a human bladder carcinoma cell line
8. Relevance of DT-diaphorase activity to mitomycin C (MMC) efficacy on human cancer cells: Differences in in vitro and in vivo systems
9. DT-diaphorase. Purification from the soluble fraction of rat-liver cytoplasm, and properties
10. Nonparametric estimation from incomplete observations
11. Soluble diaphorase in animal tissues
12. DT-diaphorase and cancer chemotherapy
13. Chemoprotection against cancer by phase 2 enzyme induction
14. High levels of expression of NAD(P)H: Quinone oxidoreductase (NQO1) gene in tumor cells compared to normal cells
15. Cytosolic NAD(P)H: Quinone acceptor oxidoreductase in human normal and tumor tissue. Effects of cigarette smoking and alcohol
16. Reductase enzyme expression across the National Cancer Institute tumor cell line panel: Correlation with sensitivity to mitomycin C and EO9
17. Unusually marked hypoxic sensitization to indoloquinone EO9 and mitomycin C in a human colon-tumour cell line that lacks DT-diaphorase activity
18. Metabolism of mitomycin C by DT-diaphorase: Role of mitomycin C-induced DNA damage and cytotoxicity in human colon carcinoma cells
19. Rapid communications. The sensitivity of human tumour cells to quinone bioreductive drugs: What role for DT-diaphorase?
20. Enhancement of mitomycin C cytotoxicity to hypoxic tumor cells by dicoumarol in vivo and in vitro
21. Metabolism of bioreductive antitumor compounds by purified rat and human DT-diaphorases
22. Chinese hamster ovary cell lines resistant to mitomycin C under aerobic but not hypoxic conditions are deficient in DT-diaphorase
23. Human FAD-dependent NAD(P)H diaphorase
24. Characterization of a polymorphism in NAD(P)H: Quinone oxidoreductase (DT-diaphorase)
25. Genotype-phenotype relationships in studies of a polymorphism in NAD(P)H: Quinone oxidoreductase 1
26. Role of DT-diaphorase mutation in the response of anal canal carcinoma to radiation, 5-fluorouracil, and mitomycin C
27. DT-diaphorase expression and tumor cell sensitivity to 17-allyamino, 17-demethoxygeldanamycin, an inhibitor of heat shock protein 90